Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,722 | -39,128 | -74,865 | -94,176 | -27,255 |
| Depreciation Amortization | 15,483 | 110,908 | 594 | 655 | 171 |
| Accounts receivable | 4,993 | -68,231 | -7,840 | -2,129 | N/A |
| Accounts payable and accrued liabilities | -5,903 | 6,465 | -3,422 | 5,569 | 1,298 |
| Other Working Capital | 18,181 | 64,551 | -2,503 | 12,715 | 3,336 |
| Other Operating Activity | 17,751 | 94,825 | 21,018 | 2,313 | 883 |
| Operating Cash Flow | $27,783 | $169,390 | $-67,018 | $-75,053 | $-21,567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,438 | -5,477 | -990 | -477 | -362 |
| Net Acquisitions | N/A | N/A | N/A | -2,500 | N/A |
| Purchase Sale Intangibles | N/A | -18,877 | N/A | N/A | 0 |
| Other Investing Activity | 0 | -18,877 | 0 | 0 | 0 |
| Investing Cash Flow | $-6,438 | $-24,354 | $-990 | $-2,977 | $-362 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,021 | N/A | N/A | N/A |
| Debt Repayment | 0 | -132,000 | -2,667 | -2,667 | -1,345 |
| Common Stock Issued | 2,863 | 5,342 | 36,215 | 138,225 | 72,546 |
| Other Financing Activity | -822 | -560 | -68 | 0 | 44,791 |
| Financing Cash Flow | $2,041 | $-117,197 | $33,480 | $135,558 | $115,992 |
| Beginning Cash Position | 146,633 | 118,794 | 153,322 | 95,794 | 1,634 |
| End Cash Position | 170,019 | 146,633 | 118,794 | 153,322 | 95,697 |
| Net Cash Flow | $23,386 | $27,839 | $-34,528 | $57,528 | $94,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,783 | 169,390 | -67,018 | -75,053 | -21,567 |
| Capital Expenditure | -6,438 | -5,477 | -990 | -477 | -362 |
| Free Cash Flow | 21,345 | 163,913 | -68,008 | -75,530 | -21,929 |